For tumors without viral etiologies, vaccines targeting cancer-associated mucin 1 (MUC1) have been evaluated in patients with colon adenoma as a premalignant disease or resected non–small cell lung cancer (35, 36). This evidence concerns the gene MUC1 and lung cancer.